Serum Cytokine Profiles of Melanoma Patients and Their Association with Tumor Progression and Metastasis

Autor: Wang X, Montoyo-Pujol YG, Bermudez S, Corpas G, Martin A, Almazan F, Cabrera T, López-Nevot MA

Publikováno v: Journal of Oncology
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname

PURPOSE: Previous studies have shown that melanoma cells produce excessive levels of cytokines, which have various biological roles during melanoma development. The aim of this study was to expand the profile of serum cytokines, chemokines, growth fa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::8c88fdc052787f512e46b56f1fddb54e
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861916/

HLA-DRB1 ∗ 16:01 and HLA-DQB1 ∗ 05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma.

Autor: Wang X; Servicio de Análisis Clínicos e Inmunología, Hospital Universitario Virgen de las Nieves, Avda. Fuerzas Armadas s/n, Granada 18014, Spain.; Programa de Doctorado en Biomedicina, Universidad de Granada, Granada, Spain., Almazan F; Programa de Doctorado en Biomedicina, Universidad de Granada, Granada, Spain.; Servicio de Dermatología, Hospital Universitario Clinico San Cecilio (PTS), Av. de la Investigación, s/n, Granada 18016, Spain., Montoyo-Pujol YG; Servicio de Análisis Clínicos e Inmunología, Hospital Universitario Virgen de las Nieves, Avda. Fuerzas Armadas s/n, Granada 18014, Spain., Martin-Casares A; Servicio de Análisis Clínicos e Inmunología, Hospital Universitario Virgen de las Nieves, Avda. Fuerzas Armadas s/n, Granada 18014, Spain., Martin A; Servicio de Anatomía Patológica, Hospital Universitario Virgen de las Nieves, Avda. Fuerzas Armadas s/n, Granada 18014, Spain., Cabrera T; Departamento Bioquímica, Biología Molecular e Inmunología III, Universidad de Granada, Granada, Spain., López-Nevot MA; Servicio de Análisis Clínicos e Inmunología, Hospital Universitario Virgen de las Nieves, Avda. Fuerzas Armadas s/n, Granada 18014, Spain.; Departamento Bioquímica, Biología Molecular e Inmunología III, Universidad de Granada, Granada, Spain.; Instituto de Investigación Biosanitaria I ibs. GRANADA, Avda de Madrid 15, Pabellón de Consultas Externas 2, Granada 18012, Spain.

Publikováno v: Journal of oncology [J Oncol] 2021 Sep 30; Vol. 2021, pp. 3801143. Date of Electronic Publication: 2021 Sep 30 (Print Publication: 2021).

Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium.

Autor: Sánchez-Maldonado JM; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Campa D; Department of Genetics, University of Pisa, Pisa, Italy., Springer J; Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany., Badiola J; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Niazi Y; Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Moñiz-Díez A; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Hernández-Mohedo F; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., González-Sierra P; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Ter Horst R; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands., Macauda A; Department of Genetics, University of Pisa, Pisa, Italy.; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Brezina S; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Cunha C; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Guimarães, Portugal., Lackner M; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria., López-Nevot MA; Immunology department, Virgen de las Nieves University Hospital, Granada, Spain., Fianchi L; Istituto di Ematologia, Università Cattolica del S. Cuore, Rome, Italy., Pagano L; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy., López-Fernández E; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Potenza L; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy., Luppi M; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy., Moratalla L; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Rodríguez-Sevilla JJ; Hematology department, Hospital del Mar, Barcelona, Spain., Fonseca JE; Rheumatology and Metabolic Bone Diseases department, Hospital de Santa Maria, CHLN, Lisbon, Portugal.; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon, Lisbon Academic Medical Center, Lisbon, Portugal., Tormo M; Hematology department, Hospital Clinico Universitario-INCLIVA, University of Valencia, Valencia, Spain., Solano C; Hematology department, Hospital Clinico Universitario-INCLIVA, University of Valencia, Valencia, Spain., Clavero E; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain., Romero A; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain., Li Y; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.; Centre for Individualised Infection Medicine (CiiM) & TWINCORE, joint ventures between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany., Lass-Flörl C; Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria., Einsele H; Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany., Vazquez L; Hematology department, University Hospital of Salamanca, Salamanca, Spain., Loeffler J; Universitätsklinikum Würzburg, Medizinische Klinik II, Würzburg, Germany., Hemminki K; Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Cancer Epidemiology, German Cancer Research Centre (DKFZ), 69120, Heidelberg, Germany.; Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605, Pilsen, Czech Republic., Carvalho A; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Guimarães, Portugal., Netea MG; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.; Department for Immunology & Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, 53115, Bonn, Germany., Gsur A; Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Dumontet C; Université Claude Bernard Lyon I, Lyon, France., Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Försti A; Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Jurado M; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS Granada, Granada, Spain.; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., Sainz J; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS Granada, Granada, Spain. juan.sainz@genyo.es.; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain. juan.sainz@genyo.es.; Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Complejo Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain. juan.sainz@genyo.es.; Department of Medicine, University of Granada, Granada, Spain. juan.sainz@genyo.es.

Publikováno v: Blood cancer journal [Blood Cancer J] 2020 Jul 16; Vol. 10 (7), pp. 75. Date of Electronic Publication: 2020 Jul 16.

Functional variants of MIF, INFG and TFNA genes are not associated with disease susceptibility or hearing loss progression in patients with Ménière's disease

Autor: Gázquez I, Moreno A, Requena T, Ohmen J, Santos-Perez S, Aran I, Soto-Varela A, Pérez-Garrigues H, López-Nevot A, Batuecas A, Friedman RA, López-Nevot MA, López-Escamez JA

Publikováno v: EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Variability in acute immune response genes could determine susceptibility or prognosis for Ménière's disease (MD). The cytokines tumor necrosis factor a (TNFa), macrophage migration inhibitory factor (MIF) and interferon ? (INF?) are proinflammator

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::983c8452464caebe0f5ac56167b08b8a
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2403

Disparidad en daño al ADN, Hsp70 y apoptosis, por UVA en leucocitos ovinos y humanos.

Autor: García-López, David A.¹, Ortiz-Letechipia, Jennifer¹, Bañuelos-Valenzuela, Rómulo², Reveles-Hernández, Rosa G.¹, Ramírez-Santoyo, Rosa M.¹, Sánchez-Rodríguez, Sergio H.¹ smdck@hotmail.com

Publikováno v: Revista MVZ Córdoba. may-ago2024, Vol. 29 Issue 2, p1-11. 11p.